Baird Medical Investment Holdings Ltd- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Baird Medical Investment Holdings Ltd 公司

贝尔德医疗投资控股有限公司是一家主要从事微波消融医疗器械业务的公司。该公司主要从事提供微波消融医疗器械。该医疗器械用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。

Baird Medical Investment Holdings Ltd简介



公司代码BDMD

公司名称Baird Medical Investment Holdings Ltd

上市日期Dec 13, 2021

CEOMr. Joe Ragan

员工数量143

证券类型Ordinary Share

年结日Dec 13

公司地址Room 202, 2/F, Baide Building, Building 11, No.15, Rongtong Street, Yuexiu District

城市GUANGZHOU

上市交易所NASDAQ Capital Market Consolidated

国家China

邮编- -

电话

网址https://ir.bairdmed.com/

公司代码BDMD

上市日期Dec 13, 2021

CEOMr. Joe Ragan

Baird Medical Investment Holdings Ltd公司高管



名称

名称/职务

职务

持股

持股变动

Ms. Haimei Wu

Chairman of the Board, Chief Executive Officer

18.30M

--

Mr. Joe Ragan

Director

--

Prof. Mingzhao (Michael) Xing

Independent Director

--

Mr. Lijian Xu

Independent Director

--

Mr. Rongjian Lu

Chief Technology Officer, Deputy General Manager

--

Ms. Jie Li

Acting Chief Financial Officer

--

Mr. Wei Hou

Director

--

Mr. Jin Xu

Quality Assurance Department Manager

--

Mr. Wei Xu

Merchandising Department Manager

--

Mr. Robin Yang

Investor Relations

--

名称

名称/职务

职务

持股

持股变动

Ms. Haimei Wu

Chairman of the Board, Chief Executive Officer

18.30M

--

Mr. Joe Ragan

Director

--

Prof. Mingzhao (Michael) Xing

Independent Director

--

Mr. Lijian Xu

Independent Director

--

Mr. Rongjian Lu

Chief Technology Officer, Deputy General Manager

--

Ms. Jie Li

Acting Chief Financial Officer

--

收入明细

单位: USD更新时间: 10月6日周一

FY2024

FY2023

业务USD

名称

营收

占比

MWA Needles

33.83M

91.33%

MWA Therapeutic Apparatus

3.20M

8.64%

Other Medical Devices

9.83K

0.03%

地区USD

名称

营收

占比

China (Mainland)

37.04M

100.00%

业务

地区

业务USD

名称

营收

占比

MWA Needles

33.83M

91.33%

MWA Therapeutic Apparatus

3.20M

8.64%

Other Medical Devices

9.83K

0.03%

股东统计

更新时间: 11月2日周日

持股股东

股东类型

持股股东

占比

Wu (Haimei)

71.59%

ExcelFin SPAC LLC

18.68%

Grand Fortune Capital (H.K.) Co, Ltd.

9.65%

Periscope Capital

0.49%

Highbridge Capital Management, LLC

0.49%

持股股东

占比

Wu (Haimei)

71.59%

ExcelFin SPAC LLC

18.68%

Grand Fortune Capital (H.K.) Co, Ltd.

9.65%

Periscope Capital

0.49%

Highbridge Capital Management, LLC

0.49%

股东类型

持股股东

占比

Individual Investor

71.59%

Corporation

28.32%

Investment Advisor/Hedge Fund

0.79%

Investment Advisor

0.53%

Hedge Fund

0.49%

Research Firm

0.29%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

45

538.38K

2.11%

-4.07M

2025Q2

48

25.90M

101.35%

+14.65M

2025Q1

81

6.17M

89.94%

-16.81M

2024Q4

86

6.26M

24.13%

-18.81M

2024Q3

89

6.01M

23.82%

-19.60M

2024Q2

91

6.99M

95.36%

-19.67M

2024Q1

95

7.38M

92.34%

-14.39M

2023Q4

94

1.73M

21.20%

-21.42M

2023Q3

93

4.65M

96.02%

-18.05M

2023Q2

90

5.14M

97.70%

-22.44M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Wu (Haimei)

18.30M

71.59%

+18.30M

--

May 13, 2025

ExcelFin SPAC LLC

4.77M

18.68%

-976.59K

-16.98%

May 13, 2025

Grand Fortune Capital (H.K.) Co, Ltd.

2.46M

9.65%

+2.46M

--

May 13, 2025

Periscope Capital

125.00K

0.49%

--

Jun 30, 2025

Highbridge Capital Management, LLC

125.00K

0.49%

--

Jun 30, 2025

UBS Financial Services, Inc.

91.45K

0.36%

+34.51K

+60.61%

Jun 30, 2025

Northern Trust Investments, Inc.

52.44K

0.21%

+52.44K

--

Jun 30, 2025

Susquehanna International Group, LLP

44.67K

0.17%

+44.67K

--

Jun 30, 2025

Jane Street Capital, L.L.C.

38.84K

0.15%

+38.84K

--

Jun 30, 2025

Virtu Americas LLC

26.36K

0.1%

+26.36K

--

Jun 30, 2025

持股ETF



机构名称

占比

暂无数据

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据